GENEVA, March 8 -- MAINLINE BIOSCINCES (SHANGHAI) CO., LTD. (Building 10, No. 860, Xinyang Road, Lingang Special Area, China (Shanghai) Pilot Free Trade Zone, Pudong New Area Shanghai 201422), 主流源生物科技（上海）有限公司 (中国上海市浦东新区中国（上海）自由贸易试验区临港新片区新杨公路860号10幢) filed a patent application (PCT/CN2023/115938) for "PEPTIDE TARGETING SOMATOSTATIN RECEPTOR, DRUG CONJUGATE AND USE THEREOF" on Aug 30, 2023. With publication no. W...